Finance

Beta
Lists
RCE:ASX
Recce Pharmaceuticals Ltd
A$0.52
-4.59%
(-0.025) 1D
Jun 3, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RCE...
Open
A$0.54
High
A$0.54
Low
A$0.52
Mkt. cap
149.01M
Avg. vol.
86.48K
Volume
80.33K
52-wk high
A$0.73
52-wk low
A$0.28
EPS
-A$0.11
Shares outstanding
289.18M
Open
A$0.54
High
A$0.54
Low
A$0.52
Mkt. cap
149.01M
Avg. vol.
86.48K
Volume
80.33K
52-wk high
A$0.73
52-wk low
A$0.28
EPS
-A$0.11
Shares outstanding
289.18M
News stories
From sources across the web
About Recce Pharmaceuticals Ltd
CEOJames Graham
Employees-
FoundedApr 11, 2007
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
281.26K
281.26K
206.02K
206.02K
Cost of goods sold
1.03M
1.03M
5.05M
5.05M
Cost of revenue
1.03M
1.03M
5.05M
5.05M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.02M
2.02M
2.39M
2.39M
Operating expense
5.92M
5.92M
3.01M
3.01M
Total operating expenses
6.95M
6.95M
8.06M
8.06M
Operating income
-6.67M
-6.67M
-7.86M
-7.86M
Other non operating income
-25.31K
-25.31K
-
-
EBT including unusual items
-6.85M
-6.85M
-8.28M
-8.28M
EBT excluding unusual items
-6.85M
-6.85M
-8.28M
-8.28M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
3.29M
3.29M
207.15K
207.15K
Net income
-6.85M
-6.85M
-8.28M
-8.28M
Net profit margin
-2,434.21%
-2,434.21%
-4,018.96%
-4,018.96%
Earnings per share
-
-
-
-
Interest and investment income
14.42K
14.42K
20.36K
20.36K
Interest expense
-235.51K
-235.51K
-443.69K
-443.69K
Net interest expenses
-221.09K
-221.09K
-423.33K
-423.33K
Depreciation and amortization charges
134.83K
134.83K
33.52K
33.52K
EBITDA
-6.65M
-6.65M
-7.82M
-7.82M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more